When injected into irradiated syngeneic recipients, BM cells transduced with activated AKT (MSCV-IRES-GFP-myr construct) induced a myeloproliferative disease (MPD) that progressed to either AML or ALL. Here, AKT1 is linked to acute myeloid leukemia.